Researchers at Pompeu Fabra University (UPF) have made a great leap toward predicting the risk of hip fracture among people with osteoporosis and evaluating the effectiveness of specific drugs to ...
WHO Collaborating Center for Metabolic Bone Disorders has the following research output in the current window (1 December 2024 - 30 November 2025) of the Nature Index. Click on Count to view a list of ...
Inflammatory osteolysis is a condition involving progressive bone tissue destruction and is observed in many well-known ...
Inflammation of bones is a characteristic of disorders like apical periodontitis. Researchers have found that copper-mediated ...
The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes ...
Osteoporosis is a common skeletal disorder characterized by excessive bone loss, leading to increased fragility and an increased risk of fractures. Osteoclasts, the bone-resorbing cells, are widely ...
Glucose–lipid metabolic dysfunction, increasingly prevalent with the worldwide rise in obesity, type 2 diabetes, and aging, has emerged as a critical factor ...
NEW HAVEN, CT, UNITED STATES, February 24, 2026 /EINPresswire.com/ -- Yale Associate Research Scientist Investigates ...
Researchers at King's College London have discovered that an immune protein best known for protecting the body against ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results